These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 36577425)

  • 1. Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management.
    Battistella S; D'Arcangelo F; Grasso M; Zanetto A; Gambato M; Germani G; Senzolo M; Russo FP; Burra P
    Clin Mol Hepatol; 2023 Feb; 29(Suppl):S286-S301. PubMed ID: 36577425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
    Castelló B; Aguilera V; Blázquez MT; Rubín Á; García M; Vinaixa C; Benlloch S; SanJuan F; Montalva E; López R; Berenguer M
    Ann Hepatol; 2019; 18(6):855-861. PubMed ID: 31543468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAFLD and liver transplantation: Disease burden, current management and future challenges.
    Burra P; Becchetti C; Germani G
    JHEP Rep; 2020 Dec; 2(6):100192. PubMed ID: 33163950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.
    Haldar D; Kern B; Hodson J; Armstrong MJ; Adam R; Berlakovich G; Fritz J; Feurstein B; Popp W; Karam V; Muiesan P; O'Grady J; Jamieson N; Wigmore SJ; Pirenne J; Malek-Hosseini SA; Hidalgo E; Tokat Y; Paul A; Pratschke J; Bartels M; Trunecka P; Settmacher U; Pinzani M; Duvoux C; Newsome PN; Schneeberger S;
    J Hepatol; 2019 Aug; 71(2):313-322. PubMed ID: 31071367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation.
    Lonardo A; Mantovani A; Petta S; Carraro A; Byrne CD; Targher G
    Nat Rev Endocrinol; 2022 Oct; 18(10):638-650. PubMed ID: 35840803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis.
    Saeed N; Glass L; Sharma P; Shannon C; Sonnenday CJ; Tincopa MA
    Transplantation; 2019 Nov; 103(11):e345-e354. PubMed ID: 31415032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy.
    Ferrarese A; Battistella S; Germani G; Russo FP; Senzolo M; Gambato M; Vitale A; Cillo U; Burra P
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208613
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease and liver transplantation.
    Khan RS; Newsome PN
    Metabolism; 2016 Aug; 65(8):1208-23. PubMed ID: 26997540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.
    Athyros VG; Alexandrides TK; Bilianou H; Cholongitas E; Doumas M; Ganotakis ES; Goudevenos J; Elisaf MS; Germanidis G; Giouleme O; Karagiannis A; Karvounis C; Katsiki N; Kotsis V; Kountouras J; Liberopoulos E; Pitsavos C; Polyzos S; Rallidis LS; Richter D; Tsapas AG; Tselepis AD; Tsioufis K; Tziomalos K; Tzotzas T; Vasiliadis TG; Vlachopoulos C; Mikhailidis DP; Mantzoros C
    Metabolism; 2017 Jun; 71():17-32. PubMed ID: 28521870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times.
    Gitto S; Marra F; De Maria N; Bihl F; Villa E; Andreone P; Burra P
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):173-178. PubMed ID: 30791778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances.
    Said A
    World J Gastroenterol; 2013 Dec; 19(48):9146-55. PubMed ID: 24409043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation for non-alcoholic fatty liver disease.
    Germani G; Becchetti C
    Minerva Gastroenterol Dietol; 2018 Jun; 64(2):138-146. PubMed ID: 29249127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease.
    Majumdar A; Tsochatzis EA
    Metabolism; 2020 Oct; 111S():154291. PubMed ID: 32531295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
    Mikolasevic I; Filipec-Kanizaj T; Mijic M; Jakopcic I; Milic S; Hrstic I; Sobocan N; Stimac D; Burra P
    World J Gastroenterol; 2018 Apr; 24(14):1491-1506. PubMed ID: 29662288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation and non-alcoholic fatty liver disease.
    Zezos P; Renner EL
    World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
    Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
    Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver Transplant.
    Chandrakumaran A; Siddiqui MS
    Gastroenterol Clin North Am; 2020 Mar; 49(1):165-178. PubMed ID: 32033762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation.
    Burke A; Lucey MR
    Am J Transplant; 2004 May; 4(5):686-93. PubMed ID: 15084161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Onset Diabetes and Non-Alcoholic Fatty Liver Disease after Liver Transplantation.
    Andrade AR; Bittencourt PL; Codes L; Evangelista MA; Castro AO; Sorte NB; Almeida CG; Bastos JA; Cotrim HP
    Ann Hepatol; 2017 November-December,; 16(6):932-940. PubMed ID: 29055928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
    Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.